pimecrolimus ophthalmic suspension
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pimecrolimus ophthalmic suspension, covering 2020-05-27 to 2020-05-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca [Phase 2]